Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

NARecruitingINTERVENTIONAL
Enrollment

575

Participants

Timeline

Start Date

December 10, 2009

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Crohn Disease
Interventions
OTHER

bio-banking collection

blood samples, biopsies, and surgical specimen collected in addition to usual practice

Trial Locations (17)

33

ACTIVE_NOT_RECRUITING

Haut-levêque Hospital, Bordeaux

44093

RECRUITING

Nantes Hospital, Nantes

59037

RECRUITING

Lille Hospital, Lille

63003

RECRUITING

Clermont-Ferrand Hospital, Clermont-Ferrand

69495

RECRUITING

South Lyon Hospital, Pierre-Bénite

75010

RECRUITING

Saint Louis Hospital, Paris

75012

RECRUITING

Saint Antoine Hospital, Paris

80054

RECRUITING

Amiens Hospital, Amiens

92110

RECRUITING

Beaujon Hospital, Clichy

Unknown

RECRUITING

SART Tilman Hospital, Liège

RECRUITING

Henri Mondor Hospital, Créteil

RECRUITING

Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre

RECRUITING

Hôpital Nord, CHU Marseille, Marseille

RECRUITING

Montpellier Hospital, Montpellier

RECRUITING

Brabois Hospital, Nancy

ACTIVE_NOT_RECRUITING

Strasbourg Hospital, Strasbourg

06202

RECRUITING

Archet 2 Hospital, Nice

All Listed Sponsors
lead

Saint-Louis Hospital, Paris, France

OTHER

NCT03458195 - Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group | Biotech Hunter | Biotech Hunter